NSAIDs, Cox-2 inhibitors, and the gut.
Hayllar
J
J
Mount Isa Base Hospital, Queensland, Australia.
Bjarnason
I
I
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000494:pharmacology*; D002074:Butanones / Q000009:adverse effects / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D004008:Diclofenac / Q000009:adverse effects / Q000494:pharmacology; D004064:Digestive System / Q000187:drug effects*; D006801:Humans; D007189:Indans / Q000009:adverse effects / Q000494:pharmacology; D000077430:Nabumetone; D009288:Naproxen / Q000009:adverse effects / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010894:Piroxicam / Q000009:adverse effects / Q000494:pharmacology; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000145:classification
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D016861:Cyclooxygenase Inhibitors; D007189:Indans; D011448:Prostaglandin Antagonists; D010894:Piroxicam; D004008:Diclofenac; D009288:Naproxen; D011451:Prostaglandin-Endoperoxide Synthases; C059178:flosulide; D000077430:Nabumetone